Aarey Drugs & Pharmaceuticals Ltd. (IN:AAREYDRUGS)

:AAREYDRUGS

AAREYDRUGS

Aarey Drugs & Pharmaceuticals Ltd.

RESEARCH TOOLSreports

Aarey Drugs & Pharmaceuticals Ltd. (AAREYDRUGS) Price & Analysis

0 Followers

AAREYDRUGS Stock Chart & Stats

₹68.03

-₹1.15(-1.99%)

At close: Jan 09 4:00 PM EST

₹68.03

-₹1.15(-1.99%)

Day’s Range― - ―

52-Week Range₹46.35 - ₹100.00

Previous CloseN/A

Volume4.04K

Average Volume (3M)7.61K

Market Cap

₹1.77B

Enterprise Value₹2.29B

Total Cash (Recent Filing)₹81.90M

Total Debt (Recent Filing)₹507.79M

Price to Earnings (P/E)84.5

Beta1.14

Next Earnings

May 28, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.20

Shares Outstanding28,354,303

10 Day Avg. Volume5,578

30 Day Avg. Volume7,610

Financial Highlights & Ratios

PEG Ratio-1.15

Price to Book (P/B)0.75

Price to Sales (P/S)0.22

P/FCF Ratio-23.99

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Conservative LeverageA low debt-to-equity ratio (0.25) reduces fixed interest obligations and refinancing vulnerability. Over a 2-6 month horizon this conservatism supports liquidity and financial flexibility, enabling management to allocate cash to operations or restructuring without heavy leverage constraints.

Strong Equity PositionA high equity ratio (58.09%) means a larger buffer of shareholder capital against asset write-downs or working capital stress. This structural strength lowers insolvency risk and gives the company room to absorb cyclical shocks or invest modestly in product or process improvements.

Positive EBITDA MarginA positive EBITDA margin (2.55%) shows the business can cover variable costs and some fixed overhead, indicating core operations are not loss-making. If revenue stabilizes or cost control improves, EBITDA provides a base to rebuild net profitability and cash generation sustainably.

Bears Say

Steep Revenue DeclineA >30% year-over-year revenue decline is a structurally adverse trend that erodes scale economics, reduces bargaining power with suppliers, and compresses fixed-cost absorption. Unless demand stabilizes, sustained top-line weakness will impair margin recovery and investment capacity.

Very Weak MarginsExtremely thin gross and operating margins leave little room to absorb cost inflation or pricing pressure. Persistent low margins constrain reinvestment into R&D, marketing, or quality controls and make the business vulnerable to competitors with better cost structures over the medium term.

Poor Cash ConversionNegative free cash flow and a 0.22 OCF-to-net-income ratio indicate weak conversion of accounting profits into cash. This limits funds for capex, working capital, or debt servicing, raising the risk of liquidity strain and forcing dependence on external financing or equity to sustain operations.

AAREYDRUGS FAQ

What was Aarey Drugs & Pharmaceuticals Ltd.’s price range in the past 12 months?

Aarey Drugs & Pharmaceuticals Ltd. lowest stock price was ₹46.35 and its highest was ₹100.00 in the past 12 months.

What is Aarey Drugs & Pharmaceuticals Ltd.’s market cap?

Aarey Drugs & Pharmaceuticals Ltd.’s market cap is ₹1.77B.

When is Aarey Drugs & Pharmaceuticals Ltd.’s upcoming earnings report date?

Aarey Drugs & Pharmaceuticals Ltd.’s upcoming earnings report date is May 28, 2026 which is in 48 days.

How were Aarey Drugs & Pharmaceuticals Ltd.’s earnings last quarter?

Aarey Drugs & Pharmaceuticals Ltd. released its earnings results on Feb 11, 2026. The company reported ₹0.2 earnings per share for the quarter, beating the consensus estimate of N/A by ₹0.2.

Is Aarey Drugs & Pharmaceuticals Ltd. overvalued?

According to Wall Street analysts Aarey Drugs & Pharmaceuticals Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Aarey Drugs & Pharmaceuticals Ltd. pay dividends?

Aarey Drugs & Pharmaceuticals Ltd. pays a Notavailable dividend of ₹0.1 which represents an annual dividend yield of N/A. See more information on Aarey Drugs & Pharmaceuticals Ltd. dividends here

What is Aarey Drugs & Pharmaceuticals Ltd.’s EPS estimate?

Aarey Drugs & Pharmaceuticals Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Aarey Drugs & Pharmaceuticals Ltd. have?

Aarey Drugs & Pharmaceuticals Ltd. has 28,354,303 shares outstanding.

What happened to Aarey Drugs & Pharmaceuticals Ltd.’s price movement after its last earnings report?

Aarey Drugs & Pharmaceuticals Ltd. reported an EPS of ₹0.2 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 3.754%.

Which hedge fund is a major shareholder of Aarey Drugs & Pharmaceuticals Ltd.?

Currently, no hedge funds are holding shares in IN:AAREYDRUGS

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Aarey Drugs & Pharmaceuticals Ltd.

Aarey Drugs & Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients, bulk drugs, intermediates, and specialty chemicals for various industrial applications in India. The company provides mono methyl and die methyl urea, ortho para nitro anisole, 2 bromomethyl 1,3 dioxalane, uracile and active pharma ingredients, such as metformin HCL, mefenamic acid, and doxophylline. It also offers chemicals and solvents, which include aeromatics chemicals, chemical acids, chlor alkalies, glycols and glycol ethers, fiber intermediates, acetates and esters, and chlorinated solvents, as well as industrial alchols, ketones, amines, oleochemicals, intermediates, olefines, phosphates, fertilizers, monomers, and chemicals. The company's pharmaceutical products are used by pharmaceutical formulation manufacturers and pharmaceutical merchant exporters. It also trades in industrial solvents and chemicals. Aarey Drugs & Pharmaceuticals Limited was incorporated in 1990 and is headquartered in Mumbai, India.